Concourse Financial Group Securities’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2244 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3920 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3912 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3952 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3967 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3904 |
|
|
2023
Q3 | – | Sell |
-6
| Closed | -$44 | – | 3871 |
|
|
2023
Q2 | $44 | Hold |
6
| – | – | ﹤0.01% | 2314 |
|
|
2023
Q1 | $62 | Buy |
+6
| New | +$62 | ﹤0.01% | 2340 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3714 |
|
|
2022
Q3 | – | Sell |
-56
| Closed | -$2K | – | 3499 |
|
|
2022
Q2 | $2K | Sell |
56
-75
| -57% | -$2.68K | ﹤0.01% | 2012 |
|
|
2022
Q1 | $5K | Sell |
131
-57
| -30% | -$2.18K | ﹤0.01% | 1843 |
|
|
2021
Q4 | $8K | Hold |
188
| – | – | ﹤0.01% | 1907 |
|
|
2021
Q3 | $9K | Buy |
188
+157
| +506% | +$7.52K | ﹤0.01% | 1905 |
|
|
2021
Q2 | $2K | Sell |
31
-77
| -71% | -$4.97K | ﹤0.01% | 2173 |
|
|
2021
Q1 | $10K | Sell |
108
-627
| -85% | -$58.1K | ﹤0.01% | 1762 |
|
|
2020
Q4 | $66K | Buy |
735
+250
| +52% | +$22.4K | 0.01% | 1059 |
|
|
2020
Q3 | $50K | Sell |
485
-95
| -16% | -$9.79K | ﹤0.01% | 1058 |
|
|
2020
Q2 | $46K | Buy |
580
+92
| +19% | +$7.3K | ﹤0.01% | 1020 |
|
|
2020
Q1 | $28K | Sell |
488
-49
| -9% | -$2.81K | ﹤0.01% | 1109 |
|
|
2019
Q4 | $29K | Buy |
537
+283
| +111% | +$15.3K | ﹤0.01% | 1137 |
|
|
2019
Q3 | $13K | Sell |
254
-31
| -11% | -$1.59K | ﹤0.01% | 1076 |
|
|
2019
Q2 | $14K | Sell |
285
-1,780
| -86% | -$87.4K | ﹤0.01% | 1374 |
|
|
2019
Q1 | $104K | Sell |
2,065
-183
| -8% | -$9.22K | 0.01% | 674 |
|
|
2018
Q4 | $133K | Buy |
2,248
+2,065
| +1,128% | +$122K | 0.02% | 548 |
|
|
2018
Q3 | $12K | Buy |
+183
| New | +$12K | ﹤0.01% | 1033 |
|